UVA Health scientists are reporting promising success as they pioneer a new way to create vaccines far more quickly, nimbly ...
Elegen sets a new benchmark for clonal, cell-free synthetic DNA with ENFINIA, delivering unmatched length and accuracy from ...
In this second of three articles on The Sunday Times top 100 tech companies list, pharmaphorum is focusing on the first nine ...
The problem of antibiotic-resistant bacteria has many health experts worried. As disease-causing bacteria adapt to some of ...
Danaher (NYSE:DHR) closed 2025 with what management described as a “strong finish” and better-than-expected performance ...
Elegen today announced significant price reductions across its ENFINIAtm DNA portfolio, now offering high-accuracy, clonal, cell-free synthetic DNA with list pricing as low as $0.07 per base pair.
Ortiz, a junior majoring in Chemical and Biomolecular Engineering working as the undergraduate lab manager in the Betenbaugh ...